Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
444.6 INR | +1.02% | +1.62% | +3.36% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.36% | 2.88B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Laurus Labs Ties Up with Indian Institute for Novel Gene Therapy Advancement in India